Yang Jun-ho, CEO of Biobizz: "Celivion to Enter Japan in First Half of Next Year; Finalizing Terms with Local Partner"
Predicted impact: Low
Biobijou바이오비쥬
489460 · KOSDAQ · ₩489460 · 바이오비쥬
₩12,780▲ ₩450 (3.65%)End-of-day · Oct 26, 2026 · End-of-day prices.
Price · 1Y −19.22%
- Market cap
- ₩189B
- Enterprise value
- —
- P/E
- 28.9×
- P/B
- —
- Dividend yield
- 0.8%
- ROE
- —
- Net margin
- 22.8%
Trailing 12 months from filed financial statements, as of H1 2026. Dividend yield: the 2025 dividend per share from the annual report ÷ today's price.
52-week range−20.6% from the high
₩5,230Today: ₩12,200 – ₩12,830₩16,090
Returns
- 1W+2.2%
- 1M+6.9%
- 3M+41.7%
- 6M+47.1%
- YTD−5.2%
- 1Y−17.2%
- Volume today
- 143,604
- 1.5× the 20-day average
- Traded today
- ₩1.8B
- Listed shares
- 14,753,287
- EPS (12 months)
- ₩442
- Earnings yield 3.5%
AI research · InitiationBiobijou: Profitable but Richly Priced Against a Model Estimate After a Strong 3-Month RallyThe data shows a small, profitable company with improving trailing margins, a recent buyback and cancellation, and a possible Japan launch mentioned by management.Read the full report →
Upcoming dates
Full calendar →🎁 Gift this stock
Send a friend ₩100,000 of paper money in this stock. They get it when they join.
Signals
Normal- BuzzNormalBuzz 53 of 100 (50 is a normal day for this stock).
- MomentumStrong12.5% over the last month; the price is above its 20-day average.
- News impactLow1 news items and filings in two weeks; 0 rated high impact, 0 medium.
Signals describe activity, not recommendations. Not financial advice.
Biobijou stock overview
Biobijou (바이오비쥬, KRX: 489460) is listed on KOSDAQ, in the Chemicals sector. The company researches, develops, manufactures and sells skin booster and hyaluronic acid (HA) filler products for the global aesthetic market, operating mainly as an export-focused business. Its shares closed at ₩12,780 on Oct 26, 2026, up 3.65% on the day, giving it a market value of ₩189B.
Key facts
- Market cap
- ₩189B
- Sector
- Chemicals
- Latest price change
- +3.65%
- As of
- Oct 26, 2026
- Main business
- The company researches, develops, manufactures and sells skin booster and hyaluronic acid (HA) filler products for the global aesthetic market, operating mainly as an export-focused business.
Quick answers about Biobijou
- What does Biobijou do?
- The company researches, develops, manufactures and sells skin booster and hyaluronic acid (HA) filler products for the global aesthetic market, operating mainly as an export-focused business. Its products include the CANDOLOV SERUM and ASCENART skin boosters, COLENA PREMIUM and CANDOLOV HA fillers, and OEM contract manufacturing for brand customers, with its own manufacturing plant in Hanam, Gyeonggi-do, Korea. It also distributes Botulinum toxin products and CDL skincare, which is sold direct-to-consumer in North America.
- What is the market cap of Biobijou?
- The market capitalisation of Biobijou was ₩189B at the close on Oct 26, 2026.
- Who are the largest shareholders of Biobijou?
- According to the latest official filings, the largest reported holders are Cheongdam Global (50.85%, as of May 20, 2025); Mysen Holding Co. (6.22%, as of May 20, 2025).
- When is the next earnings report from Biobijou?
- Korean companies rarely announce results dates in advance. Based on when Biobijou filed the same report in past years, its next 3q results is expected around Nov 14, 2026.
Company profile
The company researches, develops, manufactures and sells skin booster and hyaluronic acid (HA) filler products for the global aesthetic market, operating mainly as an export-focused business. Its products include the CANDOLOV SERUM and ASCENART skin boosters, COLENA PREMIUM and CANDOLOV HA fillers, and OEM contract manufacturing for brand customers, with its own manufacturing plant in Hanam, Gyeonggi-do, Korea. It also distributes Botulinum toxin products and CDL skincare, which is sold direct-to-consumer in North America.
Written by AI from the company's latest annual report.
- Korean name
- 바이오비쥬
- Sector
- Chemicals
- Themes
- K-beauty
- CEO
- 양준호
- Founded
- Jul 2018
- Listed
- May 2025
- Listed shares
- 14,753,287
- Fiscal year ends
- Month 12
- Website
- www.biobijou.co.kr/
Similar companies
- LG Chem051910 · ₩16T₩225,000−1.75%
- Hanwha Solutions009830 · ₩6T₩26,500−6.85%
- Hanwha000880 · ₩4.9T₩91,200−2.36%
- SKC011790 · ₩3.9T₩79,100−3.77%
- KCC002380 · ₩3.2T₩368,000−3.16%
- Kumho Petro Chemical011780 · ₩2.6T₩102,500−5.27%
- Soulbrain357780 · ₩2.2T₩288,500−4.79%
- Hansol Chemical014680 · ₩2.2T₩204,000−4.00%
Recent news
Recent filings
See all- 5%+ holding reportOct 2, 2026
- Results of Securities Issuance (Voluntary Disclosure) (1st Convertible Bonds)Sep 18, 2026
- Convertible bond issue decisionSep 10, 2026
- Half-year report (Jun 2026)Aug 12, 2026
- Share cancellation decisionJul 2, 2026
Titles in Korean until English translations are added.
Also known as: Biobijou / 바이오비쥬 / 489460 / KRX:489460
Source: KRX statistical information